Wilson Sonsini Goodrich & Rosati advised Venrock on IP related matters related to the transaction. Lycia Therapeutics, Inc., a biotechnology company, announced it raised $106.6 million...
You must be a Standard 1 Year member to access this content.
Jones Day and Cooley are representing Reneo Pharmaceuticals, Inc. in the transaction, and Wilson Sonsini Goodrich & Rosati, P.C. is representing OnKure, Inc. Covington & Burling...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Block on the offering, and Simpson Thacher & Bartlett advised the initial purchasers. Block, Inc. (NYSE: SQ) (“Block” or the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised DoorDash on the transaction. DoorDash Inc. (NYSE: DASH) announced that it has entered into an amendment agreement pursuant to which...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Lagrange Labs in the transaction. Lagrange Labs announced a $13.2 million Seed Round, led by Founders Fund. The round included...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pascal on IP matters related to this transaction. Pascal announced it has raised an $8 million seed round led by...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SR One, Norwest Venture Partners, and Delos Capital on the transaction. Zenas BioPharma, a clinical-stage global biopharmaceutical company, announced an...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Soleno Therapeutics on the offering, and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advised the underwriters. Soleno Therapeutics, Inc....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Karius on IP matters related to the transaction. Karius®, Inc. (Karius), a world leader in genomic diagnostics for infectious disease,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aledade on the transaction. Aledade, the nation’s largest and most successful network of physician-led value-based care, announced that it has...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction. Health tech company, Transcarent announced?raising $126 million in Series D funding round led by General Catalyst and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Enlaza on IP matters related to the transaction. Enlaza Therapeutics (Enlaza), the first covalent biologic platform company, announced it closed...
You must be a Standard 1 Year member to access this content.
